Immunexpress Awarded BARDA Contract to Develop SeptiCyte(R) RA...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEATTLE, June 16, 2020 /PRNewswire-AsiaNet/-- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, has been awarded a grant from the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant...
Authors: LATEST ASIANET NEWS RELEASES